Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > A Second Life for MAP, a Model Amphipathic Peptide
Publication

Publications

A Second Life for MAP, a Model Amphipathic Peptide

Title
A Second Life for MAP, a Model Amphipathic Peptide
Type
Article in International Scientific Journal
Year
2022
Authors
Silva, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Kurrikoff, K
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Langel, U
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Almeida, AJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 23
Final page: 8322
ISSN: 1661-6596
Publisher: MDPI
Indexing
Other information
Authenticus ID: P-00W-Y37
Resumo (PT):
Abstract (EN): Cell-penetrating peptides (CPP) have been shown to be efficient in the transport of cargoes into the cells, namely siRNA and DNA, proteins and peptides, and in some cases, small therapeutics. These peptides have emerged as a solution to increase drug concentrations in different tissues and various cell types, therefore having a relevant therapeutic relevance which led to clinical trials. One of them, MAP, is a model amphipathic peptide with an alpha-helical conformation and both hydrophilic and hydrophobic residues in opposite sides of the helix. It is composed of a mixture of alanines, leucines, and lysines (KLALKLALKALKAALKLA). The CPP MAP has the ability to translocate oligonucleotides, peptides and small proteins. However, taking advantage of its unique properties, in recent years innovative concepts were developed, such as in silico studies of modelling with receptors, coupling and repurposing drugs in the central nervous system and oncology, or involving the construction of dual-drug delivery systems using nanoparticles. In addition to designs of MAP-linked vehicles and strategies to achieve highly effective yet less toxic chemotherapy, this review will be focused on unique molecular structure and how it determines its cellular activity, and also intends to address the most recent and frankly motivating issues for the future.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 13
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Vanadium Compounds with Antidiabetic Potential (2023)
Another Publication in an International Scientific Journal
Amaral, LMPF; Moniz, T; Silva, AMN; Maria Rangel
Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis (2019)
Another Publication in an International Scientific Journal
Ferreira, N; Maria Joao Saraiva; Almeida, MR
Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems (2019)
Another Publication in an International Scientific Journal
Souto, EB; Dias Ferreira, J; Oliveira, J; Sanchez Lopez, E; Lopez Machado, A; Espina, M; Garcia, ML; Souto, SB; Martins Gomes, C; Silva, AM
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents-A Review (2024)
Another Publication in an International Scientific Journal
Coimbra, S; Rocha, S; Sousa, NR; Cristina Catarino; Belo, L; Bronze da Rocha, E; Valente, MJ; Santos-Silva, A
Therapeutic Approaches for Age-Related Macular Degeneration (2022)
Another Publication in an International Scientific Journal
Galindo-Camacho, RM; Blanco-Llamero, C; da Ana, R; Fuertes, MA; Senorans, FJ; Silva, AM; Garcia, ML; Souto, EB

See all (284)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-10 at 02:57:40 | Privacy Policy | Personal Data Protection Policy | Whistleblowing